13 November 2014 - Geneva, Switzerland - A new study found that the use of the Xpert MTB/RIF test in the 22 high TB burden countries is primarily limited to people in whom drug-resistant TB is suspected or to a lesser extent people living with HIV in whom TB needs to be diagnosed. The exceptions are South Africa, Brazil and Russia who currently recommend this test for all people in whom TB is suspected. South Africa alone had procured 66% of the tests procured globally.

WHO and the European Respiratory Society present a new framework to eliminate tuberculosis in countries with low levels of the disease.

The European Respiratory Society (ERS) offers a short-term fellowship each year to support the developing research skills of young doctors from low- and middle-income countries working in the field of tuberculosis. The one-to-three month project should be carried out in a European research centre.